Uro-Oncology

Specialized Approach to Cancers of the Urinary Tract and Reproductive System

Uro-Oncology
  • What is Uro-Oncology?

    Uro-oncology is a subspecialty within oncology that focuses on the diagnosis, treatment, and management of cancers affecting the urinary system and male reproductive organs. This field encompasses malignancies of the kidneys, bladder, ureters, urethra, and prostate. Uro-oncologists integrate multidisciplinary approaches, utilizing surgical interventions, medical therapies, and radiation treatments to address these cancers. Advances in imaging and diagnostic techniques, such as endoscopy and molecular profiling, have improved the precision of uro-oncological care.

  • Common Urological Cancers

    In uro-oncology, common cancers include bladder cancer, renal cell carcinoma, prostate cancer, and testicular cancer. Bladder cancer, often diagnosed via cystoscopy and imaging, is managed with intravesical therapy, radical cystectomy, or immunotherapy. Renal cell carcinoma is typically treated through partial or radical nephrectomy, with additional options including targeted therapy and immunotherapy for advanced cases. Prostate cancer management may involve active surveillance, radical prostatectomy, or androgen deprivation therapy. Testicular cancer, usually identified through ultrasound and tumor markers, is primarily treated with orchiectomy and adjuvant chemotherapy if needed.

  • Innovations in Uro-Oncology Treatments

    Uro-oncology is marked by significant advancements, including minimally invasive techniques like robotic-assisted laparoscopic surgery, which offer enhanced precision and quicker recovery compared to traditional open surgery. The field has also seen advancements in systemic therapies, including targeted agents and immune checkpoint inhibitors, which are tailored based on genetic and molecular tumor profiles. These innovations are improving the management of localized and advanced uro-oncological cancers, aiming for personalized treatment strategies that enhance patient outcomes and quality of life.

Robotics in Uro-Oncology: Revolutionizing Surgical Precision

Robotics in Uro-Oncology: Revolutionizing Surgical Precision

Integrating Robotics into Urological Cancer Treatment

  • Enhanced Precision: Minimally invasive techniques for accurate tumor removal
  • Reduced Recovery Time: Quicker healing due to smaller incisions
  • Optimized Outcomes: Improved control of cancer with fewer complications
  • Advanced Visualization: High-definition imaging for better surgical guidance
  • Reduced Blood Loss: Precision tools minimize hemorrhage during procedures

Uro-Oncology: A Specialized Branch of Oncology

Uro-Oncology: A Specialized Branch of Oncology

Precision in Managing Urinary Tract Malignancies

  • Specialized Cancer Management: Focuses on renal, bladder, and prostate cancers
  • Multimodal Treatment Strategies: Utilizes surgery, systemic therapy, and radiation
  • Individualized Treatment Plans: Adapts approaches based on cancer type and progression
  • Integrated Care Approach: Combines surgical, medical, and supportive therapies
  • Cutting-Edge Research: Investigates new therapies and improves patient outcomes

Our Expert Doctors

Our team

Dr. Harshit Garg-oncology charitable trust
Dr. Harshit Garg

Urologist, Urologist, Urology Oncologist and Robotics

Dr. Anshul Gupta-oncology charitable trust
Dr. Anshul Gupta

Oncologist

Dr. Neha Singh-oncology charitable trust
Dr. Neha Singh

Pain and Palliative Medicine Specialist

Dr Sumanth Bhollu-oncology charitable trust
Dr Sumanth Bhollu

Head and Neck Surgeon

Dr. VINEET NAKRA-oncology charitable trust
Dr. VINEET NAKRA

Radiation Oncologist

Location & Location Map

Location
addressAddress

3rd FLOOR, PLOT NO.4, PUSHPANJALI ENCLAVE, East Delhi 110092, Delhi

Working Hours

MONDAYClosed
TUESDAYClosed
WEDNESDAYClosed
THURSDAYClosed
FRIDAYClosed
SATURDAYClosed
SUNDAYClosed

Contact Us

Contact Us

  • Email: Tormsforum@gmail.com
  • Phone: 9971703341

Website Powered by icareheal

© TRUST FOR ONCOLOGY, ROBOTICS AND MEDICAL SCIENCES (TORMS 2025